Liver Cancer Diagnostic Market Revenue Drivers, Growth Opportunities, Value Chain Analysis and Forecast Research Report, 2025
“The global Liver Cancer Diagnostic Market scope was projected at US$ 8.25 billion in 2017. It is expected to reach US$ 15.4 billion by 2025 with a CAGR of 8.1% during the forecast period.”
The global Liver Cancer Diagnostic Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development. Market Overview: The global Liver Cancer Diagnostic Market scope was projected at US$ 8.25 billion in 2017. It is expected to reach US$ 15.4 billion by 2025 with a CAGR of 8.1% during the forecast period. Liver cancer diagnostic refers to advanced medical techniques used in healthcare facilities to confirm the presence of unwanted cell growth in the human body. Continuous exposure to carcinogenic substances and changes in deoxyribonucleic acid (DNA) can damage tumor suppressor genes. Permanent damage to suppressor genes can lead to the growth of abnormal cells affected organ. Hepatocellular Carcinoma (HCC) is considered the most common form of primary liver cancer in adults. The growing prevalence of liver cancer owing to unhealthy eating and drinking habits is anticipated to propel liver cancer diagnostics market growth. Regular consumption of spicy or unhygienic food and alcohol can damage the liver. Growing awareness among people regarding importance of early diagnosis of the disease is expected to impel liver cancer diagnostic industry growth. Detection of the problem at early stage is likely to increase possibilities of cure through chemotherapy or other effective treatments. Moreover, the advent of multiple screening procedures that are helping healthcare professionals to detect the problem at the initial stage will drive the liver cancer diagnostics industry over the forecast period. Available laboratory tests for HCC include urinalysis, sputum cytology, immunophenotyping, and urine cytology. These tests allow healthcare professionals to detect abnormalities in tissue structure and cells inside humans.